Brief report: Tumor necrosis factor and interleukin-6 differentially regulate dkk-1 in the inflamed arthritic joint

Arthritis and Rheumatology

Volumn 67, Issue 8, 2015, Pages 2071-2075

  Yeremenko, Nataliya ^a   Zwerina, Karin ^b   Rigter, Gemma ^a   Pots, Desiree ^a   Fonseca, Joao E ^c   Zwerina, Jochen ^b   Schett, Georg ^b   Baeten, Dominique ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^c HOSPITAL DE SANTA MARIA   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; DICKKOPF 1 PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; MESSENGER RNA; ONCOSTATIN M; TUMOR NECROSIS FACTOR; DKK1 PROTEIN, HUMAN; IL1B PROTEIN, HUMAN; IL6 PROTEIN, HUMAN; SIGNAL PEPTIDE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CYTOKINE PRODUCTION; DISEASE DURATION; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; JOINT BIOPSY; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION; SPONDYLARTHRITIS; STROMA CELL; SYNOVIAL FLUID; SYNOVIOCYTE; SYNOVIUM; UPREGULATION; CELL CULTURE; CYTOLOGY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MIDDLE AGED; SPONDYLOARTHROPATHY;

ADULT; ARTHRITIS, RHEUMATOID; CELLS, CULTURED; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION REGULATION; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; INTERLEUKIN-1BETA; INTERLEUKIN-6; MALE; MIDDLE AGED; RNA, MESSENGER; SPONDYLARTHROPATHIES; SYNOVIAL FLUID; SYNOVIAL MEMBRANE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84938149893     PISSN: 23265191     EISSN: 23265205     Source Type: Journal    
DOI: 10.1002/art.39183     Document Type: Article

References (17)

1. Baron R, Rawadi G., Wnt signaling and the regulation of bone mass. Curr Osteoporos Rep 2007; 5: 73-80.
2. Diarra D, Stolina M, Polzer K, Zwerina J, Ominsky MS, Dwyer D, et al., Dickkopf-1 is a master regulator of joint remodeling. Nat Med 2007; 13: 156-63.
3. Uderhardt S, Diarra D, Katzenbeisser J, David JP, Zwerina J, Richards W, et al., Blockade of Dickkopf (DKK)-1 induces fusion of sacroiliac joints. Ann Rheum Dis 2010; 69: 592-7.
4. Heiland GR, Appel H, Poddubnyy D, Zwerina J, Hueber A, Haibel H, et al., High level of functional dickkopf-1 predicts protection from syndesmophyte formation in patients with ankylosing spondylitis. Ann Rheum Dis 2012; 71: 572-4.
5. De Rooy DP, Yeremenko NG, Wilson AG, Knevel R, Lindqvist E, Saxne T, et al., Genetic studies on components of the Wnt signalling pathway and the severity of joint destruction in rheumatoid arthritis. Ann Rheum Dis 2013; 72: 769-75.
6. Vandooren B, Noordenbos T, Ambarus C, Krausz S, Cantaert T, Yeremenko N, et al., Absence of a classically activated macrophage cytokine signature in peripheral spondylarthritis, including psoriatic arthritis. Arthritis Rheum 2009; 60: 966-75.
7. Dougados M, van der Linden S, Juhlin R, Huitfeldt B, Amor B, Calin A, et al., and the European Spondylarthropathy Study Group. The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy. Arthritis Rheum 1991; 34: 1218-27.
8. Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO III, et al., 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum 2010; 62: 2569-81.
9. Yeremenko N, Noordenbos T, Cantaert T, van Tok M, van de Sande M, Canete JD, et al., Disease-specific and inflammation-independent stromal alterations in spondylarthritis synovitis. Arthritis Rheum 2013; 65: 174-85.
10. Appel H, Ruiz-Heiland G, Listing J, Zwerina J, Herrmann M, Mueller R, et al., Altered skeletal expression of sclerostin and its link to radiographic progression in ankylosing spondylitis. Arthritis Rheum 2009; 60: 3257-62.
11. Honsawek S, Tanavalee A, Yuktanandana P, Ngarmukos S, Saetan N, Tantavisut S., Dickkopf-1 (Dkk-1) in plasma and synovial fluid is inversely correlated with radiographic severity of knee osteoarthritis patients. BMC Musculoskelet Disord 2010; 11: 257.
12. Daoussis D, Liossis SN, Solomou EE, Tsanaktsi A, Bounia K, Karampetsou M, et al., Evidence that Dkk-1 is dysfunctional in ankylosing spondylitis. Arthritis Rheum 2010; 62: 150-8.
13. Charles P, Elliott MJ, Davis D, Potter A, Kalden JR, Antoni C, et al., Regulation of cytokines, cytokine inhibitors, and acute-phase proteins following anti-TNF-α therapy in rheumatoid arthritis. J Immunol 1999; 163: 1521-8.
14. Brandt J, Haibel H, Cornely D, Golder W, Gonzalez J, Reddig J, et al., Successful treatment of active ankylosing spondylitis with the anti-tumor necrosis factor α monoclonal antibody infliximab. Arthritis Rheum 2000; 43: 1346-52.
15. Shimamoto K, Ito T, Ozaki Y, Amuro H, Tanaka A, Nishizawa T, et al., Serum interleukin 6 before and after therapy with tocilizumab is a principal biomarker in patients with rheumatoid arthritis. J Rheumatol 2013; 40: 1074-81.
16. Briot K, Rouanet S, Schaeverbeke T, Etchepare F, Gaudin P, Perdriger A, et al., The effect of tocilizumab on bone mineral density, serum levels of Dickkopf-1 and bone remodeling markers in patients with rheumatoid arthritis. Joint Bone Spine 2015; 82: 109-15.
17. Terpos E, Fragiadaki K, Konsta M, Bratengeier C, Papatheodorou A, Sfikakis PP., Early effects of IL-6 receptor inhibition on bone homeostasis: a pilot study in women with rheumatoid arthritis. Clin Exp Rheumatol 2011; 29: 921-5.